Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5

American Journal of Nephrology
Vatsa DavePeter F Mount

Abstract

Denosumab, a RANK-ligand inhibitor, is an effective treatment for osteoporosis in postmenopausal women and men. Unlike the bisphosphonates, it is not excreted by the kidney. Little is known, however, about its efficacy and safety in patients with severe chronic kidney disease (CKD). A retrospective study was performed in CKD 4-5D patients from a tertiary referral hospital who were treated with denosumab between 1st January 2011 and 31st March 2014. Data collected included information about the following: CKD stage, fracture history, bone mineral density, serum calcium levels pre and post denosumab treatment, episodes of hypocalcemia, relevant medications and adverse events. Eight patients with CKD-5 and 6 patients with CKD-4 were identified (all female, mean age 77.1 ± 9.9). The mean pre-denosumab calcium value was 2.42 ± 0.12 mmol/l, PTH 20.2 ± 14.7 pmol/l and 25-OH vitamin D 69.1 ± 30.1 nmol/l. After denosumab treatment, 6/8 patients with CKD-5/5D, and 2/5 patients with CKD-4 developed severe hypocalcemia. Two patients developed direct adverse complications of hypocalcemia (seizure, laryngospasm, prolonged QTc). Among the patients who developed hypocalcemia, the median time to serum calcium nadir was 21 days and the median ti...Continue Reading

Citations

Dec 25, 2015·Expert Opinion on Drug Safety·Maurizio RossiniDavide Gatti
Oct 31, 2015·Climacteric : the Journal of the International Menopause Society·F Milat, A J Vincent
Nov 3, 2016·Pharmacoepidemiology and Drug Safety·Andrew Liem Hieu HuynhDouglas Forsyth Johnson
Aug 16, 2016·Annals of the New York Academy of Sciences·Michael Pazianas, Bo Abrahamsen
Apr 22, 2017·Nephrology·Matthew J Damasiewicz, Peter R Ebeling
Feb 3, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Prakirthi YerramOsama Abdelghany
Oct 21, 2017·Future Oncology·Andrew J Yee, Noopur S Raje
Jan 25, 2018·Internal Medicine Journal·Julia E ShrosbreeJacqueline R Center
Jan 26, 2018·Annals of Clinical Biochemistry·J S Kenkre, Jhd Bassett
Oct 12, 2018·Internal Medicine Journal·Jasna AleksovaRichard J MacIsaac
Mar 26, 2019·The Journal of Clinical Endocrinology and Metabolism·Richard EastellDolores Shoback
Sep 8, 2018·British Journal of Clinical Pharmacology·Michael Kriegbaum SkjødtBo Abrahamsen
Dec 16, 2019·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·G TsvetovT Diker-Cohen
Feb 6, 2020·Clinical Endocrinology·Lik-Hui LauMathis Grossmann
Jan 20, 2016·Current Opinion in Nephrology and Hypertension·Andrew L Lundquist, Sagar U Nigwekar
Sep 24, 2020·International Journal of Molecular Sciences·Chia-Yu HsuKuo-Hu Chen
Aug 28, 2020·BMJ Case Reports·Natasha Daga, Flavian Joseph
Jun 24, 2017·Journal of Community Hospital Internal Medicine Perspectives·Sohail Abdul SalimVenkataraman Palabindala
May 2, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C ThongprayoonW Cheungpasitporn
Dec 21, 2018·BMJ Case Reports·Kanramon WatthanasuntornRosana Gnanajothy
Sep 7, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D MiyaokaM Inaba
Nov 22, 2018·JBMR Plus·Matthew J Damasiewicz, Thomas L Nickolas
Dec 7, 2018·Case Reports in Nephrology·Ryan JallehShilpanjali Jesudason
Apr 23, 2017·Journal of Nephrology·Jordi BoverMario Cozzolino
Aug 12, 2016·The Medical Journal of Australia·Frances Milat, Peter R Ebeling
May 4, 2018·Frontiers in Endocrinology·Jana BrunovaJitka Stepankova
May 29, 2019·Current Opinion in Rheumatology·Susan M Ott
Nov 20, 2020·The Journal of Clinical Endocrinology and Metabolism·Aaron BroadwellPaul D Miller
Feb 11, 2021·Drug and Therapeutics Bulletin·Natasha Daga, Flavian Joseph
Feb 6, 2021·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rikako HiramatsuAkinori Sakai
Jul 13, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Merav BarPaul A Carpenter
Apr 1, 2021·Nature Reviews. Nephrology·Frank BridouxNelson Leung
Mar 29, 2021·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael Pazianas, Paul D Miller
Mar 31, 2021·Clinical and Translational Medicine·Young Jong KoWonbong Lim
Jun 9, 2021·Kidney International·Mathias HaarhausUNKNOWN Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis
Jun 8, 2021·Clinical Kidney Journal·Felix Perez-VillaÀngel Argilés
Jul 8, 2021·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S Y ParkH Y Chung
Jul 29, 2021·Archives of Osteoporosis·Aquila GopaulKristin K Clemens
Aug 24, 2021·Kidney International·Susan M OttGrahame J Elder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved